Boston Scientific Corporation (NYSE: BSX) identified a cybersecurity incident on August 25, 2026, causing global operational disruptions. The breach limits access to systems critical for processing and shipping customer orders.

The company activated its incident response plan and engaged third-party cybersecurity experts to contain the threat. In a Wednesday SEC filing, Boston Scientific noted that system access remains limited and the timeline for full restoration is currently unknown.

Operational Impact

The incident has disrupted key operational aspects, specifically limiting the ability to process and ship customer orders. These limitations are expected to continue as the investigation proceeds. The company has not determined whether the incident is reasonably likely to have a material impact on the company.

Recent Financial Context

Amid the cyber incident, Boston Scientific reported revenues of $5.442 billion for the recent quarter, beating the consensus estimate of $5.361 billion and management guidance of $5.34 billion-$5.44 billion. However, the company had previously cut its fiscal 2026 outlook, citing pressures in the Watchman and EP markets.

Boston Scientific shares were down 4.32% at $47.70 at the time of publication on Wednesday.

Boston Scientific (NYSE: BSX) has delivered an average annual return of 15.01% over the past 15 years, outperforming the broader market by 1.54% on an annualized basis. The medical device manufacturer currently commands a market capitalization of $76.81 billion.

The long-term performance highlights the impact of compounded growth on investor capital. An individual who invested $1,000 in BSX stock 15 years ago would see that position valued at $8,480.30 today. This calculation is based on a share price of $51.68 at the time of writing.

Performance Metrics

The following table outlines the key performance indicators for Boston Scientific stock over the specified period.

What the Numbers Show

The data illustrates a significant divergence between nominal investment and realized value through compounding. While the absolute gain of $7,480.30 on a $1,000 base appears substantial, it is driven by the consistent application of the 15.01% annualized return rate over a 15-year horizon. This suggests that the primary value driver for long-term holders has been sustained capital appreciation rather than short-term volatility or dividend reinvestment, given the focus on price-based valuation in the source data.